Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eli Lilly
Pharma
Lilly touts Zepbound-Taltz combo in patients with obesity, PsA
Taking Zepbound with Taltz could help patients with both obesity and psoriatic arthritis more than Taltz on its own, according to new Eli Lilly data.
Fraiser Kansteiner
Jan 8, 2026 2:00pm
Lilly, J&J launches top Clarivate's Drugs to Watch 2026 report
Jan 7, 2026 9:28am
How Lilly's 2026 Olympics team-ups align with its own mission
Dec 17, 2025 4:45pm
Novo's oral semaglutide is PCPs' most-anticipated obesity med
Dec 15, 2025 3:46pm
Lilly shifts oral SERD hopes to its largest oncology trial ever
Dec 12, 2025 11:45am
Lilly to build $6B API plant in Alabama to produce obesity pill
Dec 9, 2025 3:30pm
